New Delhi: In view of the increasing opposition to the Agneepath scheme, the central government has taken a big decision. The government has increased...
Garching, Munich, Germany & Lausanne, Switzerland:ITM gains exclusive global development and commercialization rights to Debiopharm’s first-in-class, peptide-based theranostic pair which combines therapeutic...